WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997020940) COMPOSITIONS AND METHOD FOR STIMULATING ANTIBODY RELEASE BY B LYMPHOCYTES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/020940    International Application No.:    PCT/US1996/019327
Publication Date: 12.06.1997 International Filing Date: 05.12.1996
Chapter 2 Demand Filed:    12.06.1997    
IPC:
A61K 38/00 (2006.01), A61K 38/19 (2006.01), A61K 38/20 (2006.01), A61K 39/39 (2006.01), C07K 14/315 (2006.01), C07K 14/535 (2006.01), C07K 14/55 (2006.01), C07K 14/74 (2006.01), C07K 16/24 (2006.01)
Applicants: HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE [US/US]; Suite 600, 1401 Rockville Pike, Rockville, MD 20852 (US)
Inventors: MOND, James, J.; (US).
SNAPPER, Clifford, M.; (US)
Agent: GARRETT, Arthur, S.; Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., 1300 I Street, N.W., Washington, DC 20005-3315 (US)
Priority Data:
08/568,343 06.12.1995 US
Title (EN) COMPOSITIONS AND METHOD FOR STIMULATING ANTIBODY RELEASE BY B LYMPHOCYTES
(FR) COMPOSITIONS ET PROCEDE SERVANT A STIMULER LA LIBERATION D'ANTICORPS PAR LES LYMPHOCYTES B
Abstract: front page image
(EN)The invention describes compositions comprising adding granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3), or a combination thereof useful for stimulating the release of antibody by B cells. Methods of using the compositions, pharmaceutical compositions, vaccines, and vaccines adjuvants are also described. In addition, this invention describes an assay system useful for identifying compounds capable of stimulating the release of antibody by B cells.
(FR)L'invention concerne des compositions comprenant le facteur de stimulation de populations de macrophages granulocytes (GM-CSF), interleukine-3 (IL-3) ou leur combinaison servant à stimuler la libération d'anticorps par les lymphocytes B. Elle concerne également des procédés d'utilisation de ces compositions, des compositions pharmaceutiques, des vaccins, ainsi que des adjuvants de vaccins. Elle concerne, de plus, une technique permettant d'identifier des composés capables de stimuler la libération d'anticorps par les lymphocytes B.
Designated States: AU, CA, JP.
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)